Dr. Lin is a faculty member with expertise in epidemiology and biostatistics in the University of Pittsburgh Department of Anesthesiology and Perioperative Medicine. She leads the statistical team for our Clinical and Translational Research Center on grant development, statistical analysis, and data and safety monitoring for clinical trials. Dr. Lin is proficient in epidemiological methodology with independent research and quantitative analytical skills. She has more than 10 years of research experience in study design, data processing, data quality control, statistical analysis, data interpretation, manuscript preparation, multicenter clinical trials, and large real-world electronic health records. Throughout her career, Dr. Lin has collaborated with multidisciplinary experts and scientists on various research projects funded by NIH. These experiences have demonstrated her capability to facilitate multicenter complex protocols, carry out studies successfully, and produce impactful and influential research outcomes in the health sciences.
- PhD, Epidemiology, University of Pittsburgh
- MS, Occupational Medicine and Industrial Hygiene, National Taiwan University, Taiwan
- BS, Public Health, Taipei Medical University, Taiwan
Education & Training
- Perrillo R, Lin HS, Schwarz KB, Rosenthal P, Lisker-Melman M, Chung RT, Prokunina-Olsson L, Coherty G, Feld J; Hepatitis B Research Network (HBRN). Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B. Hepatology. 2022 Feb 21. doi: 10.1002/hep.32400. Epub ahead of print. PMID: 35188674.
- Ling SC, Lin HH, Murray KF, Rosenthal P, Mogul D, Rodriguez-Baez N, Schwarzenberg SJ, Teckman JH, Schwarz KB and Hepatitis B Research Network. Chronic hepatitis is common and often untreated among children with hepatitis B infection in the United States and Canada. J Pediatr. 2021 Oct. 237:24-33.e12. PMID: 34022250
- Evon DM*, Lin HH*, Fontana RJ, Khalili M, Yim CK, Wahed AS, Hoofnagle JH. Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B. GastroHep. 2021 May;3(3):196-208. PMID: 34421369 (*joint first authors)
- Lin HS, Naimi AI, Brooks MM, Richardson GA, Burke JG, Bromberger JT. Life-course impact of child maltreatment on midlife health-related quality of life in women: longitudinal mediation analysis for potential pathways. Annals of Epidemiology Epub 2020 Jan 18. PMID: 32127250
- Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS; Hepatitis B Research Network (HBRN). Entecavir and peginterferon alfa-2a in adults with HBeAg-positive immune tolerant chronic hepatitis B virus infection. Hepatology. 2019 Dec 14. doi: 10.1002/hep.30417. PMID: 30549279.
Dr. Lin's full publication list can be reviewed through Google Scholar and NCBI.
Dr. Lin’s research interests include clinical trials, pain management, chronic liver diseases, glaucoma, health disparities, child maltreatment, patient-reported outcomes, and causal inference methods in population health.
Reduction of opioid requirement associated with Auriculo-nerve stimulation following open surgery 1R01DA054513, 2022-2026, National Institute on Drug Abuse. This randomized placebo-controlled clinical trial aims to investigate if the NSS-2 Bridge Device® will be an effective opioid-sparing tool in patients undergoing open surgery.
- PI: Jacques E. Chelly, MD, PhD, MBA
- Role: Co-Investigator